Menu Search
Equities

Owens & Minor Inc

OMI:NYQ

Owens & Minor Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)12.23
  • Today's Change0.34 / 2.86%
  • Shares traded376.67k
  • 1 Year change-34.28%
  • Beta0.4012
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy1
Outperform1
Hold4
Sell2
Strong Sell0

Share price forecast in USD

The 7 analysts offering 12 month price targets for Owens & Minor, Inc. have a median target of 14.00, with a high estimate of 25.00 and a low estimate of 12.50. The median estimate represents a 14.47% increase from the last price of 12.23.
High104.4%25.00
Med14.5%14.00
Low2.2%12.50

Dividends in USD

Historical dividend information is not available for Owens & Minor Inc.
Div growth (TTM)--
More ▼

Earnings history & estimates in USD

On Nov 04, 2024, Owens & Minor, Inc. reported 3rd quarter 2024 earnings of 0.42 per share. This result was in line with the consensus of the 7 analysts following the company and under-performed last year's 3rd quarter results by 4.55%.
The next earnings announcement is expected on Feb 18, 2025.
Average growth rate+22.62%
Owens & Minor, Inc. reported annual 2023 earnings of 1.36 per share on Feb 20, 2024.
Average growth rate+68.33%
More ▼

Revenue history & estimates in USD

Owens & Minor, Inc. had 3rd quarter 2024 revenues of 2.72bn. This bettered the 2.68bn consensus of the 6 analysts covering the company. This was 7.86% above the prior year's 3rd quarter results.
Average growth rate+1.23%
Owens & Minor, Inc. had revenues for the full year 2023 of 10.33bn. This was 3.80% above the prior year's results.
Average growth rate+3.25%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.